Drug prices' Drug prices'

French pharmaceutical group Sanofi is expected to receive an exclusive license to market a new Zika vaccine. AFP/AFP/Getty Images hide caption

toggle caption
AFP/AFP/Getty Images

States Fear Price Of New Zika Vaccine Will Be More Than They Can Pay

  • Download
  • <iframe src="https://www.npr.org/player/embed/529887446/530697999" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Gilead Sciences Inc. makes the two leading drugs that can quickly cure hepatitis C infections. But most patients can't afford the expensive drugs, and states restrict their use among Medicaid patients. David Paul Morris/Bloomberg via Getty Images hide caption

toggle caption
David Paul Morris/Bloomberg via Getty Images

Should The U.S. Government Buy A Drug Company To Save Money?

  • Download
  • <iframe src="https://www.npr.org/player/embed/520430944/520576934" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An aggressive marketing campaign has made the EpiPen the go-to drug for treating anaphylaxis. Mark Zaleski/AP hide caption

toggle caption
Mark Zaleski/AP

EpiPen Manufacturer Says It Will Help With Out-Of-Pocket Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/491232665/491311810" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tim Kilroy runs a business from his home in Arlington, Mass. His insurance company quit covering the long-acting Ritalin that helps him manage his ADHD. Ellen Webber for NPR hide caption

toggle caption
Ellen Webber for NPR

Fight To Lower Drug Prices Forces Some To Switch Medication

  • Download
  • <iframe src="https://www.npr.org/player/embed/463809474/464266304" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Maria Fabrizio for NPR

Multiple Sclerosis Patients Stressed Out By Soaring Drug Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/408021704/409421455" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

New hepatitis C drugs can cost as much as $1,000 per pill. Katherine Streeter for NPR hide caption

toggle caption
Katherine Streeter for NPR

Medicare Won't Always Pay For Boomers' Pricey Hepatitis C Drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/307747798/311760028" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript